Login to Your Account

Economy is to Blame

hESC Therapy Pioneer Geron Abandons Stem Cell R&D

By Nuala Moran
BioWorld International Correspondent

Wednesday, November 16, 2011

After 15 years' effort, the world pioneer of human embryonic stem cell (hESC) therapy, Geron Inc., is abandoning the field and will be stopping recruitment to its ground-breaking Phase I acute spinal injury trial.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription